Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors

被引：0
|
作者：
Marcell Baranyi
Eszter Molnár
Luca Hegedűs
Zsófia Gábriel
Flóra Gréta Petényi
Fanni Bordás
Violetta Léner
Ivan Ranđelović
Mihály Cserepes
József Tóvári
Balázs Hegedűs
József Tímár
机构：
[1] Semmelweis University,Department of Pathology, Forensic and Insurance Medicine
[2] KINETO Lab Ltd,Department of Thoracic Surgery
[3] University Medicine Essen - Ruhrlandklinik,Department of Anatomy, Cell and Developmental Biology
[4] University Duisburg-Essen,Department of Experimental Pharmacology and the National Tumor Biology Laboratory
[5] Pázmány Péter Catholic University Faculty of Information Technology and Bionics,undefined
[6] Eötvös Loránd University,undefined
[7] National Institute of Oncology,undefined
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1059 / 1072
页数：13
相关论文
共 50 条
  • [41] KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer
    Xiao, Annie
    Fakih, Marwan
    CLINICAL COLORECTAL CANCER, 2024, 23 (03) : 199 - 206
  • [42] Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C
    Zeng, Mei
    Lu, Jia
    Li, Lianbo
    Feru, Frederic
    Quan, Chunshan
    Gero, Thomas W.
    Ficarro, Scott B.
    Xiong, Yuan
    Ambrogio, Chiara
    Paranal, Raymond M.
    Catalano, Marco
    Shao, Jay
    Wong, Kwok-Kin
    Marto, Jarrod A.
    Fischer, Eric S.
    Janne, Pasi A.
    Scott, David A.
    Westover, Kenneth D.
    Gray, Nathanael S.
    CELL CHEMICAL BIOLOGY, 2017, 24 (08): : 1005 - +
  • [43] KRAS G12C Inhibitors: New Drugs, A New Hope
    Singhal, Surbhi
    Schokrpur, Shiruyeh
    Gandara, David
    Riess, Jonathan W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (12) : 1594 - 1598
  • [44] Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLC
    Brazel, Danielle
    Nagasaka, Misako
    TARGETED ONCOLOGY, 2024, 19 (03) : 297 - 301
  • [45] Expanding the Arsenal of Clinically Active KRAS G12C Inhibitors
    Arbour, Kathryn C.
    Lito, Piro
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2609 - +
  • [46] Breaking barriers: the latest insights into KRAS G12C inhibitors
    Attieh, Fouad
    Kourie, Hampig Raphael
    FUTURE ONCOLOGY, 2024, 20 (35) : 2685 - 2688
  • [47] Overcoming resistance to KRAS G12C inhibitors in lung cancer
    Ambrogio, Chiara
    CANCER SCIENCE, 2023, 114 : 987 - 987
  • [48] Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
    Cucurull, Marc
    Notario, Lucia
    Sanchez-Cespedes, Montse
    Hierro, Cinta
    Estival, Anna
    Carcereny, Enric
    Saigi, Maria
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [49] Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers
    Khan, Husain Yar
    Nagasaka, Misako
    Li, Yiwei
    Aboukameel, Amro
    Uddin, Md. Hafiz
    Sexton, Rachel
    Bannoura, Sahar
    Mzannar, Yousef
    Al-Hallak, Mohammed Najeeb
    Kim, Steve
    Beydoun, Rafic
    Landesman, Yosef
    Mamdani, Hirva
    Uprety, Dipesh
    Philip, Philip A.
    Mohammad, Ramzi M.
    Shields, Anthony F.
    Azmi, Asfar S.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (05): : 342 - 352
  • [50] AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells
    Morimoto, Kenji
    Yamada, Tadaaki
    Hirai, Soichi
    Katayama, Yuki
    Fukui, Sarina
    Sawada, Ryo
    Tachibana, Yusuke
    Matsui, Yohei
    Nakamura, Ryota
    Ishida, Masaki
    Kawachi, Hayato
    Kunimasa, Kei
    Sasaki, Takaaki
    Nishida, Makoto
    Furuya, Naoki
    Watanabe, Satoshi
    Shiotsu, Shinsuke
    Nishioka, Naoya
    Horinaka, Mano
    Sakai, Toshiyuki
    Uehara, Hisanori
    Yano, Seiji
    Son, Bo-Kyung
    Tokuda, Shinsaku
    Takayama, Koichi
    CANCER LETTERS, 2024, 587
12345